Changes of lipid metabolism related microRNAs expression in subclinical hypothyroidism mice model
10.3760/cma.j.issn.1000-6699.2018.05.010
- VernacularTitle:小鼠亚临床甲状腺功能减退模型脂代谢相关microRNAs表达的变化
- Author:
Liya ZHANG
1
;
Wenyu JIA
;
Yunyun XU
;
Xiaoming ZHOU
;
Rui YANG
;
Ling GAO
;
Jiajun ZHAO
;
Wenbin CHEN
Author Information
1. 山东大学附属省立医院内分泌科
- Keywords:
Subclinical hypothyroidism;
Methimazole;
MicroRNAs;
Lipid metabolism
- From:
Chinese Journal of Endocrinology and Metabolism
2018;34(5):410-415
- CountryChina
- Language:Chinese
-
Abstract:
Objective To obtain a non-invasive subclinical hypothyroidism ( SCH) mouse model, and to explore microRNAs profile related to lipid metabolism in the model mice. Methods C57BL/6 male mice (8 weeks) were treated with methimazole ( MMI, 0. 08 mg/kg BW/d) to construct SCH mouse model. MicroRNAs profiling analysis was performed by real-time quantitative polymerase chain reaction ( qRT-PCR) . Results Compared with the control group, the serum thyroid stimulating hormone ( TSH ) in subclinical hypothyroidism group increased significantly (P>0.01), while the serum free thyroxine(FT4) level did not show significant difference between the two groups (P>0. 05), which was in line with the diagnostic criteria of SCH. SCH mice was accompanied by dyslipidemia and liver lipid metabolism disorders. Four lipid metabolism related miRNAs, miR-33, miR-122, miR-199a-5p, and miR-375 in the liver of SCH mice were significantly decreased compared with those of control ( P>0. 05). Conclusion The noninvasive SCH model generated by MMI and miRNAs profile provide an animal model and a molecular basis for the study of SCH related lipid metabolism disorders.
